| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 29 |
| 1 | ADALIMUMAB | 26 |
| 2 | METHOTREXATE SODIUM | 22 |
| 3 | ADALIMUMAB-AATY | 16 |
| 4 | ADALIMUMAB-ADAZ | 16 |
| 5 | ADALIMUMAB-FKJP | 16 |
| 6 | BARICITINIB | 14 |
| 7 | METHOTREXATE | 14 |
| 8 | CERTOLIZUMAB PEGOL | 13 |
| 9 | TOCILIZUMAB | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIMIPRAMINE | 8 | 0.0073 |
| 1 | BARICITINIB | 14 | 0.0046 |
| 2 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 3 | TRIPTORELIN | 4 | 0.0012 |
| 4 | ANAKINRA | 12 | 0.0007 |
| 5 | GOLIMUMAB | 5 | 0.0004 |
| 6 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 7 | ADALIMUMAB-FKJP | 16 | 0.0003 |
| 8 | ADALIMUMAB-AATY | 16 | 0.0003 |
| 9 | EVEROLIMUS TABLETS | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 12 | 0.0007 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 2 | Janus Kinase Inhibitor [EPC] | 16 | 0.0001 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 13 | 0.0001 |
| 4 | Androgen [EPC] | 2 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 6 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 56 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |